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Abstract
Background: To determine whether TG/HDL-C ratio, which has been shown to be an indicator of the metabolic
syndrome (MetS) and insulin resistance (IR), can predict cardiovascular risk factors in the Chinese Han population in
Xinjiang.
Methods: The cardiovascular risk survey (CRS) was conducted from October 2007 to March 2010. A total of 14,618
representative participants were selected using a four-stage stratified sampling method. A total of 5757 Han
participants were included in the study. The present statistical analysis was restricted to the 5595 Han subjects who
had complete anthropometric data. The sensitivity, specificity, and distance on the receiver operating characteristic
(ROC) curve in each TG/HDL level were calculated. The shortest distance in the ROC curves was used to determine
the optimal cutoff of the TG/HDL-C ratio for detecting cardiovascular risk factors.
Results: The prevalence of hypertension, hypercholesterolemia, and hypertriglyceridemia was higher with higher
TG/HDL-C ratio for both men and women. The TG/HDL-C ratio was positively associated with systolic blood
pressure, diastolic blood pressure, and serum concentrations of total cholesterol. The optimal TG/HDL-C ratio cutoffs
for predicting hypertension, dyslipidemia, diabetes, and ≥2 of these risk factors for Han adults in Xinjiang were 1.3,
1.3, 1.4, and 1.4 in men and 0.9, 1.0, 1.0, and 1.1 in women, respectively.
Conclusions: The evaluation of TG/HDL-C ratio should be considered for one of cardiovascular risk factor predictors
among Han adults in Xinjiang.
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Background
Cardiovascular disease (CVD) is the leading cause of death
in the world, and mortality due to CVD is higher in low-
and middle-income countries comparing with developed
countries. It is expected to sharply increase the disease
burden over the next 10 years [1]. CVD has become the
leading cause of death in China [2]. It was estimated that
43.8 % of deaths in Chinese adults aged ≥40 years were at-
tributed to heart disease and stroke during 1991–2000 in
a national prospective cohort study [3]. Serum lipid levels
were increasing in the Chinese population. Without effect-
ive intervention, atherosclerosis-related diseases may soar
in the near future in China [4].
Lipid metabolic disorders have been proved as one of
the pathogenesis of atherosclerosis, which is fundamen-
tal to the occurrence of CVD. Elevated serum lipid is
one of the most important risk factors for cardiovascular
disease in Western Countries as well as Asian
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populations [5–8]. High level of low-density lipoprotein
cholesterol (LDL-C) is well established in the develop-
ment of CHD, and the role of triglycerides (TG) and
high-density lipoprotein cholesterol (HDL-C) remains
controversial. Recently, some studies demonstrated that
hypertriglyceridemia is an independent predictor of
CHD and may be a stronger risk factor than previously
thought to be [9–13]. The ratio of triglyceride/high-
density lipoprotein cholesterol (TG/HDL-C), initially
proposed by Gaziano et al., is an atherogenic index that
has proven to be a highly significant independent pre-
dictor of cardiovascular disease [14]. Others have linked
a high TG/HDL-C ratio to the risk of cardiovascular
events [15, 16]. The cutoffs for the TG/HDL-C ratio are
more often used to predict metabolic syndrome (MetS)
and insulin resistance (IR) [17, 18], while few studies of
CVD have focused on Han adults.
In Xinjiang Uighur Autonomous Region northwest of
China, which is located in the center of Asia. The largest
Chinese administrative division has a unique culture and
lifestyle. The total Han population was 8.75 million in
2012 and takes 40.1 % of the total population in
Xinjiang. Several studies have reported the condition of
dyslipidemia among adults in Xinjiang [19–21], but the
association between TG/HDL ratio and cardiovascular
risk factors among Han adults in Xinjiang remains
unknown. In this study, we aimed at to investigate the
relationship between TG/HDL ratio and cardiovascular
risk factors. We also tried to calculate the optimal cutoff
points of TG/HDL ratio to predict cardiovascular risk
factors among Han adults in Xinjiang.
Methods
Sample design
Eligible patients were selected from the cardiovascular
risk survey (CRS) study, and the detailed description of
the study population and the methods were described
previously [22, 23]. Briefly, the CRS study used a 4-stage
stratified sampling method to select a representative
sample of the general population in Xinjiang, northwest
of China. The research sites included Urumqi City,
Kelamayi City, Fukang City, Turpan Prefecture, Hetian
Prefecture, and Yili Prefecture. The time period was
from October 2007 to March 2010. The selections were
made from sampling units based on geographic area,
sex, and age groups using household registries. The 4-
stage stratified sampling method was as follows: Stage 1,
according to population census data of Xinjiang in 2000,
the areas mentioned above were selected based on popu-
lation, ethnicity, geography, economic, and cultural
development level, respectively. Stage 2, according to the
ethnic aggregation status, one district or county was
randomly selected from the Han population dominated
area. Stage 3, one community or town (village) was
randomly selected from each district or county. Stage 4,
subjects aged above 35 years were randomly selected
from each community or town (village) as research
participants. The staff conducted surveys in households
and administered questionnaires. The questionnaires
included the demographic, socioeconomic, dietary, and
medical history of each participant. In total, the CRS
included 14,618 participants (5757 Hans, 4767 Uighurs,
and 4094 Kazakhs). Five thousand five hundred ninety-five
Han participants with complete data were enrolled in the
present study. Two thousand seven hundred participants
were male, and 2895 participants were female. The age of
the participants were from 35 to 101 years old with the
mean ± SD age of 53 ± 13 (men, 52 ± 13; women, 53 ± 12).
Laboratory methods
Blood samples were obtained from an antecubital vein
into vacutainer tubes containing EDTA in the morning
after an overnight fasting period. Blood samples were
centrifuged within 2 h at the survey site. Plasma was
transferred to separate labeled tubes and transported
immediately on dry ice at prearranged intervals to the
Xinjiang Key Laboratory of Cardiovascular Disease. Serum
concentrations of serum total cholesterol, triglycerides,
low-density lipoprotein (LDL), high-density lipoprotein
(HDL), and fasting glucose were measured by the Clinical
Laboratory Department of the First Affiliated Hospital of
Xinjiang Medical University with a biochemical analyzer
(Dimension AR/AVL Clinical Chemistry System, Newark,
NJ, USA) [22, 23].
Blood pressure measurement
A mercury sphygmomanometer was used to measure
blood pressure in the sitting position after a 10-min rest
period. During the 30-min preceding measurement, the
subjects were required to refrain from smoking or
consuming caffeine. The appearance of the first sound
was used to define systolic blood pressure, and the
disappearance of sound was used to define diastolic
blood pressure [24]. Two readings each of systolic and
diastolic blood pressures were recorded, and the average
of each measurement was used for data analysis. If the
first two measurements differed by more than 5 mmHg,
additional readings were taken.
Definition of risk factors
Hypertension was defined as self-reported use of
antihypertensive medication within the past 2 weeks or an
average systolic blood pressure ≥140 mmHg, an average
diastolic blood pressure ≥90 mmHg, or both. Diabetes
was defined as fasting plasma glucose ≥7.0 mmol/L, use of
insulin or oral hypoglycemic agents, or a self-reported
history of diabetes. BMI ≥ 24 (kg/m2) were defined as
overweight. Total cholesterol concentrations >6.22 mmol/
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L (240 mg/dl) were defined as hypercholesterolemia.
Triglyceride concentrations >2.26 mmol/L (200 mg/dl)
were defined as hypertriglyceridemia. LDL cholesterol
concentrations >4.14 mmol/L (160 mg/dl) were defined as
high LDL cholesterol. HDL cholesterol concentrations
<1.04 mmol/L (40 mg/dl) were defined as low HDL
cholesterol. Dyslipidemia was defined as TG ≥ 2.26 mmol/
l, TC ≥ 6.22 mmol/l, LDL-C ≥ 4.14 mmol/l, HDL-C <
1.04 mmol/l, or if receiving a lipid-lowering drug [25].
Statistical analysis
Statistical analysis was conducted using SPSS version 17.0
for Windows (SPSS Inc., Chicago, IL, USA). Continuous
variables were expressed as sex-specific means and stand-
ard deviations, and discrete variables were expressed as
sex-specific proportions. Analysis of variance was used for
continuous variables, and the chi-square test was used for
categorical variables. A value of P < 0.05 indicates a statis-
tically significant difference. Age standardization was per-
formed by the direct method by using the Han population
according to the population census data of Xinjiang in
2000 as the standard population. The sensitivity and speci-
ficity of each TG/HDL level for the detection of hyperten-
sion, dyslipidemia, diabetes, and two or more of these risk
factors were calculated by creating dichotomous variables
for each TG/HDL value. Additionally, the distance on the
receiver operating characteristic (ROC) curve of each TG/
HDL value was calculated as the square root of [(1 − sensi-
tivity)2 + (1 − specificity)2]. The TG/HDL value with the
shortest distance on the ROC curve was considered in the
determination of optimal cutoff. The overall performance
of the TG/HDL test for detecting cardiovascular risk
factors was assessed by computing the area under the
curves (AUC). An AUC of 1 is considered to have perfect
discriminatory power, and an AUC of 0.5 suggests that the
discriminatory power is no better than chance.
Results
As presented in Table 1, with the increase of TG/HDL-C,
the serum total cholesterol increased from 4.13 ± 1.13 to
5.15 ± 1.10 (P < 0.001), the fasting glucose increased from
5.15 ± 1.68 to 6.05 ± 2.66 (P < 0.001), the HDL cholesterol
decreased from 1.60 ± 0.50 to 0.93 ± 0.37 (P < 0.001), and
the LDL cholesterol decreased from 3.07 ± 0.83 to 2.63 ±
0.94 (P < 0.001) in men. In Table 2, with the increase of
TG/HDL-C, the serum total cholesterol increased from
4.22 ± 1.09 to 5.23 ± 1.24 (P < 0.001), the fasting glucose
increased from 4.88 ± 1.12 to 5.77 ± 2.03 (P < 0.001), the
HDL cholesterol decreased from 1.64 ± 0.60 to 0.85 ± 0.34
(P < 0.001), and the LDL cholesterol decreased from 3.06
± 0.95 to 2.56 ± 0.88 (P < 0.001) in women. We also
noticed the triglycerides increased from 0.85 ± 0.78 to
3.39 ± 2.27 (P < 0.001) in women with the increase of TG/
HDL-C; we did not notice the same trend in men.
The prevalence of hypercholesterolemia increased
from 16.7 to 44 % in men and from 15.7 to 49.3 % in
women as the TG/HDL-C increased (both P < 0.001),
the prevalence of low HDL cholesterol increased from
10.9 to 65.1 % in men and from 7.6 to 73.6 % in women
as the TG/HDL-C increased (both P < 0.001), and the
prevalence of diabetes and hypertriglyceridemia showed
Table 1 Age-standardized cardiovascular disease risk factors in the Chinese Han men by TG/HDL-C category




460 (16.5 %) 639 (22.9 %) 536 (19.2 %) 398 (14.3 %) 253 (9.1 %) 502 (18.0 %)
Age (years) 52.64 ± 13.20 53.99 ± 13,94 53.54 ± 13.96 51.71 ± 12.74 50.27 ± 12.30 49.44 ± 12.01 <0.001
Systolic blood
pressure (mmHg)
133.19 ± 19.69 132.92 ± 19.35 133.91 ± 17.67 135.99 ± 17.93 134.60 ± 18.43 136.92 ± 18.56 <0.001
Diastolic blood
pressure (mmHg)
86.00 ± 15.14 85.13 ± 14.80 86.86 ± 14.59 88.87 ± 15.19 87.89 ± 15.35 90.36 ± 15.39 <0.001
Total cholesterol
(mmol/L)
4.13 ± 1.13 4.42 ± 0.99 4.68 ± 0.95 4.81 ± 0.93 4.92 ± 0.99 5.15 ± 1.10 <0.001
HDL cholesterol
(mmol/L)
1.60 ± 0.50 1.39 ± 0.39 1.24 ± 0.36 1.15 ± 0.36 1.10 ± 0.36 0.93 ± 0.37 <0.001
LDL cholesterol
(mmol/L)
3.07 ± 0.83 3.03 ± 0.91 2.83 ± 0.84 2.79 ± 0.81 2.76 ± 0.88 2.63 ± 0.94 <0.001
Triglycerides
(mmol/L)
1.17 ± 1.47 1.02 ± 0.30 1.55 ± 0.49 1.99 ± 0.62 2.47 ± 0.83 3.95 ± 2.61 <0.001
Fasting glucose
(mmol/L)
5.15 ± 1.68 5.23 ± 1.93 5.39 ± 1.68 5.45 ± 1.40 5.55 ± 1.70 6.05 ± 2.66 <0.001
BMI (kg/m2) 25.07 ± 3.21 24.97 ± 3.44 25.92 ± 3.09 26.08 ± 3.03 26.07 ± 2.81 26.63 ± 3.24 <0.001
TG/HDL-C triglycerides/high-density lipoprotein cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein, BMI body mass index
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no trend as TG/HDL-C increased for both men and
women. The prevalence of hypertension increased from
21.6 to 55 % in women as the TG/HDL-C ratio in-
creased (P < 0.001); however, we did not observe any
trend in the prevalence of hypertension as TG/HDL-C
increased for men (Tables 3 and 4).
The population distribution of each TG/HDL-C ratio and
the sensitivity, specificity, and distance on the ROC curve
for the detection of hypertension, dyslipidemia, diabetes,
and ≥2 of these risk factors for men and women were
shown in Tables 5 and 6, respectively. In men, the cutoff
for dyslipidemia and hypertension was 1.3. The shortest
distances on the ROC curve of diabetes and ≥2 of these risk
factors were the same. A TG/HDL-C ratio of 1.3 appeared
to be the optimal TG/HDL-C ratio cutoff in men. In
women, the shortest distance on the ROC curve for
diabetes and dyslipidemia was 1.0. The shortest distance on
the ROC curve for hypertension was 0.9, and ≥2 of these
risk factors was 1.1. A TG/HDL-C ratio of 1.0 appeared to
be the optimal TG/HDL-C ratio cutoff in women.
The ROC curves for men and women were shown in
Fig. 1. We found that the discriminatory power of TG/
HDL-C ratio for cardiovascular risk factors was slightly
better in women than in men.
Discussion
Dyslipidemia is an important risk factor of coronary
heart disease (CVD). Although some lipid variables were
associated with the extent of coronary disease, the ratio
of triglycerides to HDL cholesterol (TG/HDL-C) showed
Table 2 Age-standardized cardiovascular disease risk factors in the Chinese Han women by TG/HDL-C category




607 (20.4 %) 988 (33.3 %) 520 (17.5 %) 358 (12.1 %) 220 (7.4 %) 276 (9.3 %)
Age (years) 48.65 ± 11.51 51.34 ± 12.11 54.40 ± 11.99 55.81 ± 11.64 56.71 ± 11.90 56.34 ± 11.25 <0.001
Systolic blood
pressure (mmHg)
123.97 ± 18.67 128.27 ± 20.33 133.87 ± 20.97 135.88 ± 20.42 139.69 ± 21.42 139.11 ± 20.68 <0.001
Diastolic blood
pressure (mmHg)
78.96 ± 15.93 81.59 ± 15.08 83.79 ± 15.55 86.07 ± 15.52 84.52 ± 15.57 87.77 ± 15.16 <0.001
Total cholesterol
(mmol/L)
4.22 ± 1.09 4.52 ± 0.96 4.88 ± 0.97 5.00 ± 0.99 5.05 ± 1.28 5.23 ± 1.24 <0.001
HDL cholesterol
(mmol/L)
1.64 ± 0.60 1.36 ± 0.36 1.21 ± 0.33 1.08 ± 0.33 0.97 ± 0.31 0.85 ± 0.34 <0.001
LDL cholesterol
(mmol/L)
3.06 ± 0.95 3.06 ± 0.95 2.73 ± 0.82 2.71 ± 0.89 2.66 ± 0.85 2.56 ± 0.88 <0.001
Triglycerides
(mmol/L)
0.85 ± 0.78 0.99 ± 0.28 1.50 ± 0.42 1.86 ± 0.57 2.15 ± 0.68 3.39 ± 2.27 <0.001
Fasting glucose
(mmol/L)
4.88 ± 1.12 5.02 ± 1.51 5.30 ± 1.46 5.46 ± 1.80 5.56 ± 1.88 5.77 ± 2.03 <0.001
BMI (kg/m2) 23.53 ± 3.26 24.00 ± 3.62 25.21 ± 3.77 25.22 ± 3.49 25.89 ± 3.39 25.86 ± 3.45 <0.001
TG/HDL-C triglycerides/high-density lipoprotein cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein, BMI body mass index















Hypertension 34.60 37.80 42.20 46.40 35.50 47.00 <0.001
Diabetes 4.90 5.50 9.30 9.00 8.30 17.10 <0.001
Hypercholesterolemia 16.70 17.40 28.00 32.20 36.80 44.00 <0.001
High LDL cholesterol 48.00 42.90 36.60 35.30 34.00 28.30 <0.001
Low HDL cholesterol 10.90 12.80 31.70 43.70 50.60 65.10 <0.001
Hypertriglyceridemia 15.30 3.30 29.70 63.10 82.60 94.40 <0.001
TG/HDL-C triglycerides/high-density lipoprotein cholesterol
Hypertension was defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or current antihypertensive drug use. Diabetes was defined as fasting plasma glucose
≥7.0 mmol/L and/or current diabetes drug use. Hypercholesterolemia was defined as TC ≥ 6.22 mmol/L, high LDL cholesterol was defined as LDL-C ≥ 4.14 mmol/L,
low HDL cholesterol was defined as HDL-C < 1.04 mmol/L, and hypertriglyceridemia was defined as TG ≥ 2.26 mmol/L
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the strongest association with extent [26]. This study
provides population-based data on the optimal cutoff of
the triglyceride to HDL cholesterol ratio for detecting
cardiovascular risk factors in Chinese Han population in
Xinjiang aged over 35 years. To our knowledge, this is
the first large-scale, population-based, cross-sectional
survey to estimate the TG/HDL-C ratio cutoff in the
Han population in Xinjiang, China. We also found a
relationship between the TG/HDL-C ratio and cardio-
vascular risk factors.
In addition, the TG to HDL-C ratio (TG/HDL-C) has
been proposed as a useful lipid parameter associated
with metabolic syndrome (MetS), insulin resistance (IR),
and cardio-metabolic risk [15, 17, 26]. It has been suc-
cessfully used in predicting the development of diabetes,
coronary heart disease, cardiovascular events, and all-
cause mortality [27–29]. MetS is a cluster of metabolic
abnormalities characterized as central obesity, a raised
level of triglycerides (TG), reduced high-density lipopro-
tein cholesterol (HDL-C), raised blood pressure (BP),
and raised fasting plasma glucose (FPG) or previously
diagnosed type 2 diabetes; all these factors are associated
with cardiovascular disease [18]. TG/HDL-C is a
relatively new atherogenic parameter for MetS, and the















Hypertension 21.60 32.00 41.80 48.30 51.40 55.00 <0.001
Diabetes 3.20 4.70 8.30 9.80 8.60 13.80 <0.001
Hypercholesterolemia 15.70 21.40 36.00 40.50 45.00 49.30 <0.001
High LDL cholesterol 44.30 43.40 28.50 28.50 30.60 25.40 <0.001
Low HDL cholesterol 7.60 15.10 35.00 52.20 62.30 73.60 <0.001
Hypertriglyceridemia 7.40 1.50 26.30 54.70 66.80 87.70 <0.001
TG/HDL-C triglycerides/high-density lipoprotein cholesterol
Hypertension was defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or current antihypertensive drug use. Diabetes was defined as fasting plasma glucose
≥7.0 mmol/L and/or current diabetes drug use. Hypercholesterolemia was defined as TC ≥ 6.22 mmol/L, high LDL cholesterol was defined as LDL-C ≥ 4.14 mmol/L,
low HDL cholesterol was defined as HDL-C < 1.04 mmol/L, and hypertriglyceridemia was defined as TG ≥ 2.26 mmol/L
Table 5 Sensitivity (Sens), specificity (Spec), and distance in the receiver operating characteristic (ROC) curvefor TG/HDL-C cutoffs in
the Chinese Han men
Hypertension Dyslipidemia Diabetes ≥2 risk factors
TG/HDL-C
cutoffs
Percentile Sens Spec Distance in
ROC curve
Sens Spec Distance in
ROC curve
Sens Spec Distance in
ROC curve
Sens Spec Distance in
ROC curve
Men % % % %
0.5 9.1 0.89 0.15 0.85 0.98 0.24 0.76 0.92 0.15 0.86 0.97 0.16 0.84
0.6 13.8 0.85 0.22 0.79 0.96 0.33 0.67 0.88 0.20 0.81 0.95 0.23 0.77
0.7 18.3 0.80 0.30 0.73 0.94 0.44 0.57 0.85 0.27 0.75 0.94 0.30 0.70
0.8 24.0 0.76 0.35 0.69 0.92 0.52 0.49 0.81 0.32 0.71 0.91 0.36 0.65
0.9 28.1 0.71 0.39 0.67 0.90 0.59 0.42 0.77 0.37 0.67 0.89 0.41 0.60
1.0 32.1 0.67 0.44 0.65 0.88 0.66 0.37 0.74 0.42 0.64 0.86 0.46 0.56
1.1 36.6 0.63 0.49 0.64 0.85 0.72 0.32 0.70 0.46 0.62 0.83 0.51 0.52
1.2 40.0 0.59 0.52 0.63 0.82 0.77 0.29 0.66 0.50 0.61 0.80 0.55 0.49
1.3 43.9 0.55 0.56 0.63 0.79 0.82 0.28 0.62 0.54 0.60 0.77 0.60 0.47
1.4 47.5 0.50 0.60 0.64 0.74 0.85 0.30 0.57 0.58 0.60 0.71 0.64 0.46
1.5 51.4 0.46 0.64 0.65 0.69 0.88 0.34 0.53 0.62 0.60 0.67 0.67 0.47
1.6 55.1 0.42 0.67 0.67 0.64 0.91 0.37 0.49 0.66 0.61 0.63 0.70 0.48
1.7 57.9 0.39 0.69 0.68 0.61 0.92 0.40 0.47 0.68 0.62 0.59 0.73 0.49
1.8 60.8 0.35 0.72 0.71 0.56 0.95 0.44 0.43 0.72 0.64 0.54 0.76 0.52
1.9 63.6 0.32 0.73 0.73 0.53 0.96 0.48 0.40 0.74 0.66 0.50 0.78 0.55
2.0 65.5 0.31 0.74 0.74 0.50 0.96 0.50 0.38 0.75 0.66 0.48 0.79 0.56
The cutoff for dyslipidemia and hypertension was 1.3 and for diabetes and ≥2 risk factors was 1.4
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Table 6 Sensitivity (Sens), specificity (Spec), and distance in the receiver operating characteristic (ROC) curve for TG/HDL-C cutoff in
the Chinese Han women
Hypertension Dyslipidemia Diabetes ≥2 risk factors
TG/HDL-C
cutoffs
Percentile Sens Spec Distance in
ROC curve
Sens Spec Distance in
ROC curve
Sens Spec Distance in
ROC curve
Sens Spec Distance in
ROC curve
Women % % % % %
0.5 14.5 0.85 0.26 0.75 0.94 0.30 0.70 0.89 0.22 0.79 0.97 0.25 0.75
0.6 21.8 0.79 0.36 0.68 0.90 0.41 0.60 0.84 0.31 0.71 0.92 0.34 0.67
0.7 29.6 0.72 0.44 0.62 0.86 0.51 0.51 0.78 0.39 0.65 0.88 0.43 0.59
0.8 37.0 0.65 0.54 0.58 0.82 0.62 0.42 0.72 0.47 0.60 0.84 0.52 0.51
0.9 43.3 0.60 0.59 0.58 0.79 0.69 0.38 0.67 0.52 0.58 0.82 0.58 0.46
1.0 47.6 0.55 0.64 0.58 0.76 0.74 0.35 0.63 0.57 0.57 0.77 0.63 0.44
1.1 51.7 0.51 0.68 0.59 0.71 0.78 0.37 0.58 0.62 0.57 0.74 0.67 0.42
1.2 55.1 0.47 0.71 0.61 0.67 0.81 0.38 0.54 0.65 0.58 0.70 0.71 0.42
1.3 59.0 0.43 0.74 0.63 0.63 0.84 0.41 0.49 0.68 0.60 0.65 0.74 0.44
1.4 62.0 0.39 0.77 0.65 0.58 0.87 0.44 0.46 0.71 0.62 0.61 0.77 0.46
1.5 65.3 0.36 0.80 0.68 0.53 0.89 0.48 0.42 0.75 0.64 0.56 0.80 0.48
1.6 68.1 0.32 0.82 0.70 0.49 0.91 0.52 0.39 0.78 0.65 0.52 0.82 0.51
1.7 70.9 0.29 0.84 0.73 0.45 0.92 0.56 0.35 0.80 0.68 0.49 0.85 0.54
1.8 73.4 0.26 0.86 0.75 0.40 0.94 0.60 0.32 0.83 0.70 0.44 0.87 0.57
1.9 75.9 0.23 0.90 0.77 0.37 0.95 0.64 0.29 0.85 0.73 0.40 0.89 0.61
2.0 77.5 0.22 0.88 0.79 0.35 0.95 0.65 0.28 0.85 0.73 0.39 0.89 0.62
The cutoff for dyslipidemia and diabetes was 1.0, for hypertension was 0.9, and for ≥2 risk factors was 1.1
Fig. 1 ROC curves to detect CVD risk factors by sex. a ROC curves for both men and women for the detection of hypertension, b dyslipidemia,
c diabetes, and d ≥2 of these risk factors
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reports on this in the Chinese population are limited.
According to the ATPIII and JIS criteria, the optimal
cutoff for TG/HDL-C was 1.6 and 1.2 in men and 1.1
and 1.1 in women, respectively. The cutoff values of the
markers to detect the MetS in Guangdong women is
0.88 [30] and 0.84 in Zhuhai women [31]; the cutoff
value in Ghanaian women is 0.61 [32]. In Canada, men
and women is 1.62 and 1.18, respectively [33]. Few stud-
ies of this cutoff value have focused on CVD in Han
adults. In the present study, based on the sensitivity,
specificity, and ROC calculations, the optimal cutoffs of
TG/HDL-C ratio for Han men and women in Xinjiang
were 1.3 and 1.0, respectively. Additionally, this study
showed an increasing trend in the prevalence of hyper-
tension, hypercholesterolemia, hypertriglyceridemia, and
diabetes with higher TG/HDL-C among Han adults.
These elevated cardiovascular risks are associated with
MetS and IR. Current studies have reported that the
cutoffs of BMI, waist circumference (WC), and waist-to-
hip ratio (WHR) in Xinjiang were slightly higher
comparing to the WHO criteria [33, 34]. Similarly, the
cutoffs of TG/HDL-C ratio in Xinjiang are slightly
higher than other regions and criterions.
The reasons why there are higher optimal cutoffs of
TG/HDL among Han adults in Xinjiang are unclear.
Possible reasons may be associated with differences in
diet, living conditions, climate, and some important
genes that regulate body fat distribution. First, the main
reason may be a difference in diet in Xinjiang Han
adults compared with Guangdong, Zhuhai, and
Ghanaian. The Han population in Xinjiang consumes
more meat, milk products, salt, and pasta than Asian
populations in other regions. Second, a characteristic
feature of the living conditions and climate in Xinjiang is
that the temperature difference during day and night is
considerable, summer is extremely hot, and winter is
extremely cold. Therefore, drinking strong wine, eating
more animal fat, and a higher salt intake in the Han
population may lead to fat deposition thicker than other
populations for adaptation to the external environment
in Xinjiang. Third, certain genes that regulate body fat
distribution may be different in different populations, so
that body fat is more likely to accumulate [35–37]. In
addition, the difference in optimal values of TG/HDL-C
ratio between populations might be due to varied body
size, physical activity, and metabolic status.
We also found that the TG/HDL-C cutoff in Han
women in Xinjiang was the same as the ATPIII and JIS
criteria, but it was higher than in Guangdong and
Ghanaian. The reason why there are higher optimal
cutoffs may be associated with differences of eating
habits and lifestyles. We also found that the cutoffs in
Han men were higher than women in Xinjiang, similar
to the ATPIII and JIS criteria. The reason why there are
higher cutoffs may be more smoking and alcohol
consumption and less exercise.
The ratio TG/HDL-C, initially proposed by Gaziano et
al., is an atherogenic index that has proven to be a highly
significant independent predictor of cardiovascular dis-
ease, even stronger than TC/HDL-C and LDL-C/HDL-C
[14]. The Copenhagen Male Study showed that TG/
HDL-C levels can more accurately detect coronary dis-
ease [38]. The possible mechanism may be that high tri-
glycerides and low HDL-C may lead to the accumulation
of small and dense LDL-C, and these LDL-C particles
may cause HDL-C particles to undergo accelerated ca-
tabolism, which could close the atherogenic circle [39,
40]. The current study indicates that the cutoff of TG/
HDL-C ratio is a good predictor of CAD [41]. This
specific ratio has the best sensitivity and specificity, and
it will be an easy, non-invasive means of predicting the
presence and extent of coronary atherosclerosis.
Strengths and limitations
Our study has several strengths. It is the first representa-
tive sample of the general adult Han population in
Xinjiang. These results may be generalized to the full adult
population of Hans aged above 35 years. Additionally, we
provided information on cutoffs and AUC for many
anthropometric and atherogenic parameters stratified by
sex. Future studies can use the cutoffs suggested here for
the screening and intervention of cardiovascular disease in
a representative sample of the adult Han population in
Xinjiang. The limitation of this study is this is a cross-
sectional study, and it may not able to predict the progno-
sis of the disorders. Future studies can use the ratio of
TG/HDL cutoffs suggested here as a reference to evaluate
the associated risk factors and intervention effects of
dyslipidemia in other adult Han population.
Conclusions
In conclusion, this study showed a TG/HDL-C ratio value
of 1.3 and 1.0 in men and women, respectively, as an
appropriate cutoff to distinguish high cardiovascular risk
patients. The continuous relationship between cardiovascu-
lar disease risk factors and triglyceride/high-density lipopro-
tein cholesterol (TG/HDL-C) ratio was documented here.
For all the anthropometric and atherogenic parameters, the
ratio of TG/HDL-C cutoff had the best predicting ability of
CVD in both men and women.
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